From: Molecular breast cancer subtypes and therapies in a public hospital of Northeastern Brazil
Luminal A | Luminal B | HER2 | TNBC | p | |||||
---|---|---|---|---|---|---|---|---|---|
(N = 64) | (N = 120) | (N = 39) | (N = 46) | ||||||
Nr | % | Nr | % | Nr | % | Nr | % | ||
Stage | |||||||||
IA | 12 | 26.67 | 29 | 29.29 | 6 | 20.69 | 4 | 10.26 | 0.4960 |
IIA | 13 | 28.89 | 34 | 34.35 | 7 | 24.14 | 14 | 35.90 | |
IIB | 8 | 17.78 | 16 | 16.16 | 9 | 31.03 | 10 | 25.64 | |
IIIA | 2 | 4.44 | 6 | 6.06 | 1 | 3.45 | 3 | 7.69 | |
IIIC | 1 | 2.22 | - | - | 1 | 3.45 | - | - | |
IV | 9 | 20.00 | 14 | 14.14 | 5 | 17.24 | 8 | 20.51 | |
Total | 45 | 99 | 29 | 39 | |||||
n/a | 19 | 21 | 10 | 7 | |||||
Adjuvant chemotherapy | |||||||||
Yes | 34 | 54.84 | 72 | 61.02 | 32 | 86.49 | 27 | 62.79 | 0.0131 |
No | 28 | 45.16 | 46 | 38.98 | 5 | 13.51 | 16 | 37.21 | |
Radiotherapy | |||||||||
Yes | 49 | 79.03 | 99 | 83.90 | 33 | 89.19 | 42 | 97.67 | 0.0462 |
No | 13 | 20.97 | 19 | 16.10 | 4 | 10.81 | 1 | 2.33 | |
Hormone therapy | |||||||||
Yes | 47 | 75.81 | 87 | 82.20 | - | - | - | - | <0.0001 |
No | 15 | 24.19 | 21 | 17.80 | 37 | 100.0 | 43 | 100.0 | |
n/a | 2 | 2 | 2 | 3 |